URAVBHAI PATEL: Open Payments
NPI 1023663887 · THE VILLAGES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$878 in 40 payments from 15 companies in 2025. Trend: 2023 $561 · 2024 $259 · 2025 $878
Food & beverage: $878
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $196 |
| Novo Nordisk Inc | 5 | $112 |
| Merck Sharp & Dohme LLC | 5 | $104 |
| Insulet Corporation | 3 | $80 |
| Actelion Pharmaceuticals US, Inc. | 2 | $61 |
| Lilly USA, LLC | 3 | $54 |
| Amgen Inc. | 2 | $43 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $43 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| Stryker Corporation | 1 | $32 |
Products named: LEQVIO, VERQUVO, Ozempic, Omnipod, UPTRAVI, ISTURISA, NEXLETOL, MOUNJARO.
Industry payments across FL — which companies pay providers there.
